Holen Sie sich die Stockscreener-App
0.571
7.15%
-0.044
Handel nachbörslich:
.54
-0.031
-5.43%
Schlusskurs vom Vortag:
$0.615
Offen:
$0.61
24-Stunden-Volumen:
89,792
Relative Volume:
1.14
Marktkapitalisierung:
$18.41M
Einnahmen:
$38.25M
Nettoeinkommen (Verlust:
$-17.87M
KGV:
-8.1571
EPS:
-0.07
Netto-Cashflow:
$4.33M
1W Leistung:
-19.77%
1M Leistung:
-24.87%
6M Leistung:
-44.02%
1J Leistung:
-47.13%
1-Tages-Spanne:
$0.5649
$0.635
1-Wochen-Bereich:
$0.5649
$0.7332
52-Wochen-Spanne:
$0.5649
$1.34
Retractable Technologies Inc Stock (RVP) Company Profile
Firmenname
Retractable Technologies Inc
Sektor
Telefon
972-294-1010
Adresse
511 Lobo Lane, Little Elm, TX
Vergleichen Sie RVP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| RVP | 0.571 | 18.41M | 38.25M | -17.87M | 4.33M | -0.07 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Retractable Technologies Inc Aktie (RVP) Neueste Nachrichten
Retractable Technologies reports loss of USD 5.1M in Q3 2024 - Medical Buyer
Retractable Technologies: Q3 Earnings Snapshot - New Haven Register
Retractable Technologies Inc (RVP) Quarterly 10-Q Report - Quartzy
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024 - The Bakersfield Californian
Retractable Technologies Reports Steep Q3 Loss as Margins Collapse, Tariffs Bite | RVP Stock News - StockTitan
Retractable Technologies CEO Thomas Shaw acquires $5,422 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock By Investing.com - Investing.com Australia
RVP stock touches 52-week low at $0.7 amid market challenges - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock - Investing.com
Disposable Syringes Market Overall Study Report 2024-2031 | B. - openPR
Feds Can Hold Proceeds During Chinese Syringe Duties Fight - Law360
Retractable Technologies CEO Thomas J. Shaw acquires $6,876 in stock - Investing.com
Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com - Defense World
Head-To-Head Comparison: Neuronetics (NASDAQ:STIM) and Retractable Technologies (NYSE:RVP) - Defense World
Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock By Investing.com - Investing.com UK
Retractable Technologies stock hits 52-week low at $0.71 By Investing.com - Investing.com Australia
Retractable Technologies CEO Thomas Shaw buys shares for $429 - Investing.com
Retractable Technologies CEO Thomas Shaw buys shares for $429 By Investing.com - Investing.com Australia
Retractable Technologies stock hits 52-week low at $0.71 - Investing.com India
Retractable Technologies CEO Thomas Shaw buys $8,180 in stock By Investing.com - Investing.com Canada
Retractable Technologies CEO Thomas Shaw buys $8,180 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $15,661 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw acquires $15,661 in stock By Investing.com - Investing.com Australia
Retractable Technologies CEO Shaw buys $6,061 in stock By Investing.com - Investing.com South Africa
Retractable Technologies CEO Shaw buys $6,061 in stock - Investing.com
Safety Syringes Market 2024-2031 Global Industry Analysis, - openPR
Smart Syringes Market Projected to Surge to USD 143.93 Million by 2031 - WhaTech
Retractable Technologies CEO Thomas J. Shaw acquires $4,632 in stock - Investing.com India
Retractable Technologies CEO Thomas J. Shaw acquires $4,632 in stock By Investing.com - Investing.com South Africa
Hypodermic Needles Market Generated Opportunities, Future - openPR
Venous Blood Collection Market to Witness Huge Growth by 2032 |Terumo, BD, Bio Rad Laboratories, Nipro - openPR
Retractable sues Becton alleging patent infringement - Reuters
Disposable Syringes Market Forecasting Dynamic Growth: - openPR
Smart Syringes Industry: Insights from Latest Research Report on Business Opportunities by (2024-2034) - IndiaPolitics.com
U.S. Disposable Syringes Market Analysis 2024-2030: Rising Vaccine Demand and Growing Adoption of - Daily Guardian Canada
U.S. Disposable Syringes Market Analysis 2024-2030: Rising - GlobeNewswire
U.S. Disposable Syringes Market Analysis 2024-2030: Rising Vaccine Demand and Growing Adoption of Self-Administered Drug Solutions - Yahoo Finance
Retractable technologies CEO buys $4.3k of company stock - Investing.com
Retractable technologies CEO buys $4.3k of company stock By Investing.com - Investing.com UK
Disposable Syringes Market 2024 Business Development, Size, Share and Opportunities 2033 - Cauverynews
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Post Register
Retractable Technologies, Inc. Files Complaint in United States Court of International Trade - StockTitan
Finanzdaten der Retractable Technologies Inc-Aktie (RVP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.70%
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):